ReviewBMC cardiovascular disorders2025
Heart failure caused by Opitz syndrome: a case report and literature review.
Review in BMC cardiovascular disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOpitz G/BBB syndrome (OS) is a disorder characterized by hypertelorism, hypospadias, and other midline anomalies, first described in 1969 by Opitz et al. The most common heart anomalies include ventricular septal defect, atrial septal defect, coarctation of the aorta, persistent left superior vena cava, patent ductus arteriosus, and patent foramen ovale. CASE PRESENTATION: A 33-year-old man presented with a history of activity-related shortness of breath, thoracic discomfort, and palpitations after mild activity over the past 20 years. The patient had a distinctive facial appearance, including telecanthus and cranial deformity. This patient with OS presented with typical congenital heart disease and severe heart failure that cannot be explained solely by congenital heart disease or other heart diseases not previously reported in this disorder. This case highlights that OS can directly lead to decreased cardiac function.
conclusionsOS is a raredisorder characterized by midline congenital malformation. Patients with OS should be followed up for longer periods to better characterize long-term outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.